Specifically in Wilms’ tumor, a recent study showed that the splicing regulator ESRP2 is repressed by DNA methylation, whereas the overexpression of ESRP2 in Wilms’ tumor cell lines promotes alternative splicing and inhibits cell proliferation both in vitro and in vivo [39]. This evidence concerns the gene ESRP2 and Wilms tumor.